Seminars in Arthroplasty
Volume 18, Issue 3 , Pages 180-183 , September 2007

Biologic Factors Influencing Osteonecrosis: Steroids, Statins, Ethanol, Human Immunodeficiency Virus and Antiretroviral Therapy, and Smoking

  • M. Ajmal, MD

      Affiliations

    • Department of Surgery, VA Medical Center, Nashville, TN.
    • ,
  • Edward Y. Cheng, MD

      Affiliations

    • Department of Orthopaedic Surgery, University of Minnesota, Minneapolis, MN.
    • Corresponding Author InformationAddress reprint requests to Edward Y. Cheng, MD, University of Minnesota, Department of Orthopaedic Surgery, 2512 South 7th Street, Suite 200, Minneapolis, MN 55454.

References 

  1. Julian BA, Quarles LD, Niemann KM. Musculoskeletal complications after renal transplantation: Pathogenesis and treatment. Am J Kidney Dis. 1992;19:99–120
  2. Ibels LS, Alfrey AC, Huffer WE, et al. Aseptic necrosis of bone following renal transplantation: Experience in 194 transplant recipients and review of the literature. Medicine (Baltimore). 1978;57:25–45
  3. Harrington KD, Murray WR, Kountz SL, et al. Avascular necrosis of bone after renal transplantation. J Bone Joint Surg Am. 1971;53:203–215
  4. Etienne G, Mont MA, Ragland PS. The diagnosis and treatment of nontraumatic osteonecrosis of the femoral head. Instr Course Lect. 2004;53:67–85
  5. Mont MA, Hungerford DS. Non-traumatic avascular necrosis of the femoral head. J Bone Joint Surg Am. 1995;77:459–474
  6. Saito SK, Ohzono K, Ono K. Early arteriopathy and postulated pathogenesis of osteonecrosis of the femoral head: The intracapital arterioles. Clin Orthop Relat Res. 1992;277:98–110
  7. Jones JP. Fat embolism, intravascular coagulation, and osteonecrosis. Clin Orthop Relat Res. 1993;292:294–308
  8. Carvalho AC, Lees RS, Vaillancourt RA, et al. Intravascular coagulation in hyperlipidemia. Thromb Res. 1976;8:843–857
  9. Cruess RL. Osteonecrosis of bone: Current concepts as to etiology and pathogenesis. Clin Orthop Relat Res. 1986;208:30–39
  10. Arlet J. Nontraumatic avascular necrosis of the femoral head: Past, present, and future. Clin Orthop Relat Res. 1992;277:12–21
  11. Cui Q, Wang GJ, Su CC, et al. The Otto Aufranc Award: Lovastatin prevents steroid induced adipogenesis and osteonecrosis. Clin Orthop Relat Res. 1997;344:8–19
  12. Li X, Cui Q, Kao C, et al. Lovastatin inhibits adipogenic and stimulates osteogenic differentiation by suppressing PPARgamma2 and increasing Cbfa1/Runx2 expression in bone marrow mesenchymal cell cultures. Bone. 2003;33:652–659
  13. Li X, Jin L, Cui Q, Wang GJ, Balian G. Steroid effects on osteogenesis through mesenchymal cell gene expression. Osteoporos Int. 2005;16:101–108
  14. Cui Q, Wang GJ, Balian G. Steroid-induced adipogenesis in a pluripotential cell line from bone marrow. J Bone Joint Surg Am. 1997;79:1054–1063
  15. Pritchett JW. Statin therapy decreases the risk of osteonecrosis in patients receiving steroids. Clin Orthop Relat Res. 2001;386:173–178
  16. Wang GJ, Cui Q, Balian G. The Nicolas Andry award: The pathogenesis and prevention of steroid-induced osteonecrosis. Clin Orthop Relat Res. 2000;370:295–310
  17. Zizic TM, Marcoux C, Hungerford DS, et al. Corticosteroid therapy associated with ischemic necrosis of bone in systemic lupus erythematosus. Am J Med. 1985;79:596–604
  18. Ono K, Tohjima T, Komazawa T. Risk factors of avascular necrosis of the femoral head in patients with systemic lupus erythematosus under high-dose corticosteroid therapy. Clin Orthop Relat Res. 1992;277:89–97
  19. Jacobs B. Epidemiology of traumatic and nontraumatic osteonecrosis. Clin Orthop Relat Res. 1978;130:51–67
  20. Maritz FJ, Conradie MM, Hulley PA, et al. Effect of statins on bone mineral density and bone histomorphometry in rodents. Arterioscler Thromb Vasc Biol. 2001;21(10):1636–1641
  21. Colwell CW, Robinson CA, Stevenson DD, et al. Osteonecrosis of the femoral head in patients with inflammatory arthritis or asthma receiving corticosteroid therapy. Orthopedics. 1996;19:941–946
  22. Wing PC, Nance P, Connell DG, et al. Risk of avascular necrosis following short term megadose methylprednisolone treatment. Spinal Cord. 1998;36:633–636
  23. Chernetsky SG, Mont MA, LaPorte DM, et al. Pathologic features in steroid and nonsteroid associated osteonecrosis. Clin Orthop Relat Res. 1999;368:149–161
  24. Hirota Y, Hirohata T, Fukuda K, et al. Association of alcohol intake, cigarette smoking, and occupational status with the risk of idiopathic osteonecrosis of the femoral head. Am J Epidemiol. 1993;137:530–538
  25. Matsuo K, Hirohata T, et al. Influence of alcohol intake, cigarette smoking, and occupational status on idiopathic osteonecrosis of the femoral head. Clin Orthop Relat Res. 1988;234:115–123
  26. Gullihorn L, Karpman R, Lippiello L. Differential effects of nicotine and smoke condensate on bone cell metabolic activity. J Orthop Trauma. 2005;19:17–22
  27. Marston SB, Gillingham K, Bailey RF, et al. Osteonecrosis of the femoral head after solid organ transplantation: A prospective study. J Bone Joint Surg Am. 2002;84A:2145–2151
  28. Ajmal M, Matas A, Kuskowski M, et al: A Reduced Incidence of Steroid Related Osteonecrosis in Diabetics. Presented at the annual meeting of the Minnesota Orthopaedic Society, May 2006
  29. Cheng EY, Klibanoff JE, Robinson HJ, et al. Total hip arthroplasty with cement after renal transplantation: Long-term results. J Bone Joint Surg Am. 1995;77:1535–1542
  30. Mittendorfer B. Sexual dimorphism in human lipid metabolism. J Nutr. 2005;135:681–686
  31. Lima JJ, Mauras N, Kissoon N, et al. Influence of sex and beta2 adrenergic receptor haplotype on resting and terbutaline-stimulated whole body lipolysis. Metabolism. 2005;54:492–499
  32. Sakamoto M, Shimizu K, Iida S, et al. Osteonecrosis of the femoral head: A prospective study with MRI. J Bone Joint Surg Br. 1997;79:213–219
  33. Fink B, Degenhardt S, Paselk C, et al. Early detection of avascular necrosis of the femoral head following renal transplantation. Arch Orthop Trauma Surg. 1997;116:151–156
  34. Cui Q, Wang Y, Saleh KJ, et al. Alcohol-induced adipogenesis in a cloned bone-marrow stem cell. J Bone Joint Surg Am. 2006;88(suppl 3):148–154
  35. Wang Y, Li Y, Mao K, et al. Alcohol-induced adipogenesis in bone and marrow: a possible mechanism for osteonecrosis. Clin Orthop Relat Res. 2003;410:213–224
  36. Wezeman FH, Gong Z. Adipogenic effect of alcohol on human bone marrow-derived mesenchymal stem cells. Alcohol Clin Exp Res. 2004;28:1091–1101
  37. Morse CG, Mican JM, Jones EC, et al. The incidence and natural history of osteonecrosis in HIV-infected adults. Clin Infect Dis. 2007;44:739–748
  38. Mahoney CR, Glesby MJ, DiCarlo EF, et al. Total hip arthroplasty in patients with human immunodeficiency virus infection: Pathologic findings and surgical outcomes. Acta Orthop. 2005;76:198–203
  39. Ries MD, Barcohana B, Davidson A, et al. Association between human immunodeficiency virus and osteonecrosis of the femoral head. J Arthroplasty. 2002;17:135–139
  40. Mary-Krause M, Billaud E, Poizot-Martin I, et al. Risk factors for osteonecrosis in HIV-infected patients: Impact of treatment with combination antiretroviral therapy. AIDS. 2006;20:1627–1635
  41. Theiss SM, Boden SD, Hair G, et al. The effect of nicotine on gene expression during spine fusion. Spine. 2000;25:2588–2594
  42. Glassman SD, Anagnost SC, Parker A, et al. The effect of cigarette smoking and smoking cessation on spinal fusion. Spine. 2000;25:2608–2615
  43. Gordon JE, Schoenecker PL, Osland JD, et al. Smoking and socio-economic status in the etiology and severity of Legg-Calve-Perthes’ disease. J Pediatr Orthop B. 2004;13:367–370
  44. Mata SG, Aicua EA, Ovejero AH, et al. Legg-Calve-Perthes disease and passive smoking. J Pediatr Orthop. 2000;20:326–330
  45. Glueck CJ, Freiberg RA, Crawford A, et al. Secondhand smoke, hypofibrinolysis, and Legg-Perthes disease. Clin Orthop Relat Res. 1998;159–167
  46. Glueck CJ, Freiberg R, Glueck HI, et al. Idiopathic osteonecrosis, hypofibrinolysis, high plasminogen activator inhibitor, high lipoprotein(a), and therapy with Stanozolol. Am J Hematol. 1995;48:213–220
  47. Jones LC, Mont MA, Le TB, et al. Procoagulants and osteonecrosis. J Rheumatol. 2003;30:783–791
  48. Glueck CJ, Freiberg RA, Sieve L, et al. Enoxaparin prevents progression of stages I and II osteonecrosis of the hip. Clin Orthop Relat Res. 2005;435:164–170

PII: S1045-4527(07)00038-7

doi: 10.1053/j.sart.2007.06.004

Seminars in Arthroplasty
Volume 18, Issue 3 , Pages 180-183 , September 2007

Article Tools